Six months after Exubera, the new inhalable insulin product by Pfizer Inc., received approval for release in the US, Canadian diabetics and doctors are still waiting. The Canadian government has not yet given the drug the green light for use in that country, and no one seems to know when that permission might come. According to the article I read on the topic, neither the company that markets Exubera nor the government will say when it might be available. When word does come, it will be through Health Canada, the country's healthy care organization.The article also quotes Dr. Edmond Ryan, an Edmonton diabetes specialist who says of inhalable insulin: "I would say the majority like it. Others just shrug their shoulders and actually find it doesn't give as tight control as with injectable insulin."
